• Cast your vote! Nivolumab vs. Brentuximab for Classical Hodgkin Lymphoma

  • Nov 8 2024
  • Length: 48 mins
  • Podcast

Cast your vote! Nivolumab vs. Brentuximab for Classical Hodgkin Lymphoma

Listen for free

View show details

  • Summary

  • In this episode, Bernie and Anthony are joined by two special guest expert hematologists:

    Dr. David Russler-Germain

    Dr. Tycel Phillips

    We discuss recent updates in the treatment of upfront Classical Hodgkin Lymphoma, including whether the SWOG S1826 and HD21 trials change practice! Will it be a landslide victory for nivolumab? Is brentuximab fired?

    Stay tuned to find out!
    Show more Show less
Show more Show less

What listeners say about Cast your vote! Nivolumab vs. Brentuximab for Classical Hodgkin Lymphoma

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available